Adjuvant Avelumab in Merkel Cell Cancer

NCT03271372 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Stage III Merkel Cell Carcinoma AJCC v8
Stage IIIB Merkel Cell Carcinoma AJCC v8
Stage IIIA Merkel Cell Carcinoma AJCC v8

Interventions

DRUG: Avelumab
OTHER: Peripheral Blood Collection
OTHER: Placebo

Sponsor

University of Washington

Collaborators

[object Object]